Anti-infectives Clinical progress of HIV-1 integrase inhibitors

Author： Al-Mawsawi Laith Q Al-Safi Rasha I Neamati Nouri

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.13, Iss.2, 2008-06, pp. : 213-225

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HIV-1 Integrase Inhibitors: An Emerging Clinical Reality

By Dayam Raveendra Al-Mawsawi Laith Q. Neamati Nouri

Drugs in R&D, Vol. 8, Iss. 3, 2007-01 ,pp. : 155-168

Adis International

Access to resources Recommend Favorite

Applications of pharmacometrics in the clinical development and pharmacotherapy of anti-infectives

By Trivedi Ashit Lee Richard E Meibohm Bernd

Expert Review of Clinical Pharmacology, Vol. 6, Iss. 2, 2013-03 ,pp. : 159-170

Informa Healthcare

Access to resources Recommend Favorite

HIV-1 Integrase Inhibitors: A Decade of Research and Two Drugs in Clinical Trial

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 10, 2004-01 ,pp. : 1059-1077

Bentham Science Publishers

Access to resources Recommend Favorite

Heat Shock Protein 90 Inhibitors as Broad Spectrum Anti-Infectives

Current Pharmaceutical Design, Vol. 19, Iss. 3, 2013-01 ,pp. : 377-386

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of aminoacyl-tRNA synthetases as novel anti-infectives

By Tao J. Schimmel P.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 8, 2000-08 ,pp. : 1767-1775

Informa Healthcare

Access to resources Recommend Favorite